Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

NCT05532852 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05532852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2022
Completion date
October 31, 2023
Enrollment
728 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia